Skip to main content
. 2020 May 22;192(27):E745–E755. doi: 10.1503/cmaj.200642

Table 2:

Risk-of-bias assessment for mortality and length-of-stay outcomes using modified risk-of-bias criteria for randomized controlled trials and nonrandomized studies

Influenza trials, mortality outcome Sequence generation Allocation concealment Blinding (patients) Blinding (health care providers) Blinding (outcome assessors) Blinding (data collectors) Blinding (data analyst) Loss to follow-up
Beigel et al., 201725 Definitely yes Definitely yes Definitely yes Definitely no Probably no Definitely yes Probably no Definitely no
Beigel et al., 201926 Definitely yes Definitely yes Definitely yes Definitely yes Definitely yes Definitely yes Definitely yes Probably yes
Davey et al., 201927 Definitely yes Definitely yes Definitely yes Definitely yes Definitely yes Definitely yes Definitely yes Definitely yes
Hung et al., 201324 Definitely yes Definitely yes Definitely yes Definitely yes Definitely yes Definitely yes Definitely yes Definitely yes
Non-RCT (SARS-CoV), mortality outcome Selection of groups Exposure assessment Outcome following exposure Baseline comparability Measurement of prognostic variables Outcome assessment Completeness of follow-up Concomitant treatments
Soo et al., 200423 Definitely no Probably yes Definitely yes Definitely no Definitely no Definitely no Definitely no Definitely no
Influenza trials, length of stay Sequence generation Allocation concealment Blinding (patients) Blinding (health care providers) Blinding (outcome assessors) Blinding (data collectors) Blinding (data analyst) Loss to follow-up
Beigel et al., 201926 Definitely yes Definitely yes Definitely yes Definitely yes Definitely yes Definitely yes Definitely yes Probably yes
Hung et al., 201324 Definitely yes Definitely yes Definitely yes Definitely yes Definitely yes Definitely yes Definitely yes Definitely yes
Beigel et al., 201725 Definitely yes Definitely yes Definitely yes Definitely no Probably no Definitely yes Probably no Definitely no

Note: RCT = randomized controlled trial, SARS-CoV = severe acute respiratory syndrome coronavirus.